AEterna Zentaris (AEterna Zentaris) PB Ratio : 0.53 (As of Apr. 25, 2024)

View and export this data going back to 2000. Start your Free Trial

What is AEterna Zentaris PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-25), AEterna Zentaris's share price is $1.97. AEterna Zentaris's Book Value per Share for the quarter that ended in Dec. 2023 was $3.75. Hence, AEterna Zentaris's PB Ratio of today is 0.53.

The historical rank and industry rank for AEterna Zentaris's PB Ratio or its related term are showing as below:

AEZS' s PB Ratio Range Over the Past 10 Years
Min: 0.28 Med: 2.51 Max: 40.11
Current: 0.53

During the past 13 years, AEterna Zentaris's highest PB Ratio was 40.11. The lowest was 0.28. And the median was 2.51.

AEZS's PB Ratio is ranked better than
91.37% of 1310 companies
in the Biotechnology industry
Industry Median: 2.38 vs AEZS: 0.53

During the past 12 months, AEterna Zentaris's average Book Value Per Share Growth Rate was -49.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -9.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of AEterna Zentaris was 53.00% per year. The lowest was -74.80% per year. And the median was -9.40% per year.

Back to Basics: PB Ratio

AEterna Zentaris PB Ratio Historical Data

The historical data trend for AEterna Zentaris's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AEterna Zentaris PB Ratio Chart

AEterna Zentaris Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

2.02

0.81

0.43

0.50

AEterna Zentaris Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
PB Ratio	Get a 7-Day Free Trial															0.43	0.41	0.43	0.46	0.50

Competitive Comparison of AEterna Zentaris's PB Ratio

For the Biotechnology subindustry, AEterna Zentaris's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AEterna Zentaris's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AEterna Zentaris's PB Ratio distribution charts can be found below:

* The bar in red indicates where AEterna Zentaris's PB Ratio falls into.

AEterna Zentaris PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

AEterna Zentaris's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	1.97	/	3.747
	=	0.53

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

AEterna Zentaris (NAS:AEZS) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

AEterna Zentaris PB Ratio Related Terms

Thank you for viewing the detailed overview of AEterna Zentaris's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

AEterna Zentaris (AEterna Zentaris) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AEterna Zentaris Inc (NAS:AEZS) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

ET8:Germany ET8:Germany AEZS:Canada

Address

222 Bay Street, Suite 3000, PO Box 53, c/o Norton Rose Fulbright Canada, LLP, Toronto, ON, CAN, M5K 1E7

Website

https://www.zentaris.com

AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland.